Showing results (11-20 of 31) with videos related to
Sort By:
Pageof 4
European Journal of Immunology|July 24, 2019
IL-33-activated murine mast cells control the dichotomy between RORγt<sup>+</sup> and Helios<sup>+</sup> T<sub>regs</sub> via the MK2/3-mediated IL-6 production in vitroNico Andreas, Franziska Weber, Isabel Meininger, et al.Plos One|April 6, 2021
Tim-3 is dispensable for allergic inflammation and respiratory tolerance in experimental asthmaCarolin Boehne, Ann-Kathrin Behrendt, Almut Meyer-Bahlburg, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 31, 2017
The p38-MK2/3 Module Is Critical for IL-33-Induced Signaling and Cytokine Production in Dendritic CellsChristiane Göpfert, Nico Andreas, Franziska Weber, et al.Experimental Dermatology|September 14, 2016
Membrane-bound stem cell factor is the major but not only driver of fibroblast-induced murine skin mast cell differentiationMandy Leist, Cathleen Annett Sünder, Sebastian Drube, et al.European Journal of Immunology|February 3, 2011
PI3Kγ deficiency delays the onset of experimental autoimmune encephalomyelitis and ameliorates its clinical outcomeLuciana Berod, Christina Heinemann, Sylvia Heink, et al.Immunology|January 11, 2021
IL-3 is essential for ICOS-L stabilization on mast cells, and sustains the IL-33-induced RORγt<sup>+</sup> T<sub>reg</sub> generation via enhanced IL-6 inductionSebastian Drube, Sylvia Müller, Franziska Weber, et al.Immunology|January 25, 2024
The Neurobeachin-like 2 protein (NBEAL2) controls the homeostatic level of the ribosomal protein RPS6 in mast cellsPhiline Wegner, Julia Drube, Lisa Ziegler, et al.Immunology|October 20, 2025
Nbeal2 Inactivation Triggers Abl1 Stabilisation and Dysregulated Subcellular Localisation of the Multi-Drug-Resistant Protein MDR1 (ABCB1) in Mast CellsRaphaela Marquardt, Nico Andreas, Ronja Herrnberger, et al.Immunology|June 18, 2021
ATP/IL-33-triggered hyperactivation of mast cells results in an amplified production of pro-inflammatory cytokines and eicosanoidsPaul M Jordan, Nico Andreas, Marco Groth, et al.Oncotarget|March 7, 2018
PTPRG and PTPRC modulate nilotinib response in chronic myeloid leukemia cellsJulia Drube, Thomas Ernst, Markus Pfirrmann, et al.Pageof 4